Nephrocare - a quality of care development programme for renal medicine : report on a WHO meeting, Copenhagen, Denmark 15-16 April 1999
AbstractAs part of a joint quality development project between the WHO Regional Office for Europe and the renal societies of Denmark, Finland, Iceland, Norway and Sweden, representatives of the societies and WHO have developed a core data set for quality of care development in renal medicine. In April 1999, representatives of 18 renal centres in the five countries met to discuss the results of an evaluation of care based on the analysis of random samples of chronic renal patients collected from 1673 patients in the centres. In an anonymous comparison of selected indicators ("bench-marking") of participating centres, there was a marked difference between centres in indicators of referral/acceptance patterns and diagnostic activity. Despite a significant improvement in blood pressure from time of first referral to follow-up, under half the patients had blood pressure below 140/90 at follow-up, the proportion varying twofold between centres. Analysis of the application of common renal therapeutic principles showed a marked variation across the centres, sug-gesting that guidelines may have little effect on clinical nephrological practice. Participants concluded that the demon-strable differences between centres were unwanted, unnecessary and possibly inequitable, and recommended that: nephrologists should assume a greater responsibility in the organization of early renal care from a secondary and tertiary prevention perspective to reduce morbidity and cost; anonymous comparison of selected indicators with feedback to centres may be a feasible method for reducing differences in quality of treatment and care for persons with renal disease; the NEPHROCARE data set is a feasible tool for quality of care development in all kinds of renal treatment and care; information on renal patients is particularly complex and should be made more easily accessible to nephrologists through the use of compatible electronic patient records incorporating the NEPHROCARE data set; the NEPHROCARE project should continue
World Health Organization. Regional Office for Europe. (1999). Nephrocare - a quality of care development programme for renal medicine : report on a WHO meeting, Copenhagen, Denmark 15-16 April 1999. Copenhagen : WHO Regional Office for Europe. http://www.who.int/iris/handle/10665/108218
EURO ; HQ
EUR/ICP/QCPH 01 02 03
Gov't Doc #EUR/ICP/QCPH 01 02 03
MetadataShow full item record
Showing items related by title and MeSH subject.
European regional consultation on the World Health Report 2000, Copenhagen, Denmark 3-4 September 2001 World Health Organization. Regional Office for Europe (EUR/01/5031604, 2001)The meeting was convened as part of the consultation process set up following the controversy sparked by The world health report 2000 and its framework for health systems performance assessment (HSPA). It was felt that the HSPA exercise had made a significant contribution to thinking on health care systems, and that to be truly effective it needed to bridge the gaps between measuring at a global level, individual functions and the interventions that result in change. It was suggested that the evaluation process should be extended to address the ...
European Forum of Medical Associations and WHO : report on a WHO meeting, Copenhagen, Denmark 6-8 February 1997 World Health Organization. Regional Office for Europe (EUR/ICP/CORD 03 03 03, 1997)At the meeting, 80 representatives from 42 associations and 12 observer organizations considered three vital public health issues : the Ljubljana Charter on Health Care Reforms; the use, misuse and abuse of drugs; and the basic principles of quality of care development (QCD) and the role of national medical associations (NMAS) in promoting it. in adopting a revised QCD handbook, NMAs agreed to attempt to develop their own policies and actions on QCD, which would be reported to the next meeting of the Forum. Major statements were adopted on tobacco ...
Implementation of WHO's revised drug strategy: rational use of drugs; and WHO'S Action Programme on Essential Drugs: draft resolution proposed by the delegations of Australia, Bahrain, Bangladesh, Belgium, Bhutan, Botswana, Cameroon, Canada, Colombia, Denmark, Eritrea, Finland, France, Georgia, Ghana, Guyana, Hungary, Iceland, Japan, Kazakhstan, Kenya, Lesotho, Lithuania, Malawi, Malaysia, Mongolia, Netherlands, New Zealand, Nicaragua, Niger, Norway, Oman, Pakistan, Qatar, Russian Federation, Slovenia, Spain, Sri Lanka, Sweden, Syrian Arab Republic, Togo, Tunisia, Turkey, Uganda, United Kingdom of Great Britain and Northern Ireland, United Republic of Tanzania, Viet Nam and Zambia World Health Assembly, 47 (A47/A/Conf.Paper No.3, 1994)